- OBD's PSE test to be used in NCI trial
- OBD develops multi-cancer diagnostic test for dogs
- Notice of Results
- OBD partners with Goodbody Clinic on PSE test
- OBD partners with The London Clinic for PSE & CiRT
- OBD and King's College London collaborate on RA
- Holding(s) in Company
- Results of GM
- OBD opens UK clinical testing facility
- Result of AGM
More ▼
Key statistics
On Monday, Oxford Biodynamics PLC (OXBOF:PKC) closed at 0.150, 1,400.00% above the 52 week low of 0.01 set on Jan 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.150 |
Average volume | -- |
---|---|
Shares outstanding | 311.86m |
Free float | 263.69m |
P/E (TTM) | -- |
Market cap | 27.10m GBP |
EPS (TTM) | -0.0729 GBP |
Data delayed at least 15 minutes, as of Apr 22 2024.
More ▼